1. AB0014 Implication of VEGFR2 in systemic lupus erythematosus: A combined genetic and structural biological approach. (23rd January 2014) Authors: Zervou, M.I.; Eliopoulos, E.; Vazgiourakis, V.; Sharma, S.; Sidiropoulos, P.; Franek, B.S.; Myrthianou, E.; Melissourgaki, M.; Niewold, T.B.; Boumpas, D.T.; Goulielmos, G.N. Journal: Annals of the rheumatic diseases Issue: Volume 71(2012)Supplement 3 Page Start: 638 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. OP0097 Autoantibodies Precede Interferon Elevation in Pre-Clinical Lupus. (10th June 2014) Authors: Munroe, M.E.; Fife, D.A.; Robertson, J.M.; Zhao, Y.D.; Bruner, B.F.; Niewold, T.B.; Tsokos, G.C.; Keith, M.P.; Harley, J.B.; James, J.A. Journal: Annals of the rheumatic diseases Issue: Volume 73:Supplement 2(2014) Page Start: 98 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. THU0022 Single Cell Interferon Signatures in Lupus Patient Monocytes Reveal a Differential Impact of Interferon Signaling Between Monocyte Subtypes. (9th June 2015) Authors: Jin, Z.; Fan, W.; Jensen, M.A.; Dorschner, J.M.; Vsetecka, D.M.; Amin, S.; Makol, A.; Ernste, F.; Osborn, T.; Moder, K.; Chowdhary, V.; Niewold, T.B. Journal: Annals of the rheumatic diseases Issue: Volume 74(2015)Supplement 2 Page Start: 200 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. THU0372 Incidence of Systemic Lupus Erythematosus (SLE) in a Population Based Cohort Using 1982, Revised 1997 ACR and 2012 SLICC Criteria. (9th June 2015) Authors: Sagar, V.; Crowson, C.; Amin, S.; Makol, A.; Ernste, F.; Osborn, T.; Moder, K.; Niewold, T.B.; Maradit-Kremers, H.; Chowdhary, V. Journal: Annals of the rheumatic diseases Issue: Volume 74(2015)Supplement 2 Page Start: 330 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. THU0381 High levels of circulating type i, ii and iii interferons define distinct patient subsets with active systemic lupus erythematosus (SLE). (12th June 2018) Authors: Oke, V.; Gunnarsson, I.; Dorschner, J.M.; Zickert, A.; Niewold, T.B.; Svenungsson, E. Journal: Annals of the rheumatic diseases Issue: Volume 77(2018)Supplement 2 Page Start: 406 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. THU0491 Genome-Wide Transcriptional Profiling of Isolated Immune Cell Populations from SLE Patients with Different Ancestral Backgrounds. (10th June 2014) Authors: Sharma, S.; JIn, Z.; Rosenzweig, E.; Rao, S.; Ko, K.; Niewold, T.B. Journal: Annals of the rheumatic diseases Issue: Volume 73:Supplement 2(2014) Page Start: 353 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗